165 related articles for article (PubMed ID: 24594737)
1. Antibodies with higher bactericidal activity induced by a Neisseria gonorrhoeae Rmp deletion mutant strain.
Li G; Xie R; Zhu X; Mao Y; Liu S; Jiao H; Yan H; Xiong K; Ji M
PLoS One; 2014; 9(3):e90525. PubMed ID: 24594737
[TBL] [Abstract][Full Text] [Related]
2. Antibody to Rmp (outer membrane protein 3) increases susceptibility to gonococcal infection.
Plummer FA; Chubb H; Simonsen JN; Bosire M; Slaney L; Maclean I; Ndinya-Achola JO; Waiyaki P; Brunham RC
J Clin Invest; 1993 Jan; 91(1):339-43. PubMed ID: 8423230
[TBL] [Abstract][Full Text] [Related]
3. Antibody to reduction modifiable protein increases the bacterial burden and the duration of gonococcal infection in a mouse model.
Gulati S; Mu X; Zheng B; Reed GW; Ram S; Rice PA
J Infect Dis; 2015 Jul; 212(2):311-5. PubMed ID: 25596304
[TBL] [Abstract][Full Text] [Related]
4. Serum resistance of Neisseria gonorrhoeae. Does it thwart the inflammatory response and facilitate the transmission of infection?
Rice PA; McQuillen DP; Gulati S; Jani DB; Wetzler LM; Blake MS; Gotschlich EC
Ann N Y Acad Sci; 1994 Aug; 730():7-14. PubMed ID: 8080215
[TBL] [Abstract][Full Text] [Related]
5. Complement-Dependent Serum Bactericidal Assays for Neisseria gonorrhoeae.
Gulati S; Rice PA; Ram S
Methods Mol Biol; 2019; 1997():267-280. PubMed ID: 31119629
[TBL] [Abstract][Full Text] [Related]
6. Immunization with recombinant truncated Neisseria meningitidis-Macrophage Infectivity Potentiator (rT-Nm-MIP) protein induces murine antibodies that are cross-reactive and bactericidal for Neisseria gonorrhoeae.
Humbert MV; Christodoulides M
Vaccine; 2018 Jun; 36(27):3926-3936. PubMed ID: 29803329
[TBL] [Abstract][Full Text] [Related]
7. Microencapsulated IL-12 Drives Genital Tract Immune Responses to Intranasal Gonococcal Outer Membrane Vesicle Vaccine and Induces Resistance to Vaginal Infection with Diverse Strains of Neisseria gonorrhoeae.
Liu Y; Hammer LA; Daamen J; Stork M; Egilmez NK; Russell MW
mSphere; 2023 Feb; 8(1):e0038822. PubMed ID: 36537786
[TBL] [Abstract][Full Text] [Related]
8. Structure of the Recombinant
Almonacid-Mendoza HL; Humbert MV; Dijokaite A; Cleary DW; Soo Y; Hung MC; Orr CM; Machelett MM; Tews I; Christodoulides M
mSphere; 2018 Oct; 3(5):. PubMed ID: 30305317
[No Abstract] [Full Text] [Related]
9. Isolation of Naturally Released Gonococcal Outer Membrane Vesicles as Vaccine Antigens.
Francis IP; Lui X; Wetzler LM
Methods Mol Biol; 2019; 1997():121-141. PubMed ID: 31119622
[TBL] [Abstract][Full Text] [Related]
10. The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae.
Semchenko EA; Tan A; Borrow R; Seib KL
Clin Infect Dis; 2019 Sep; 69(7):1101-1111. PubMed ID: 30551148
[TBL] [Abstract][Full Text] [Related]
11. Synthetic DNA Delivery of an Optimized and Engineered Monoclonal Antibody Provides Rapid and Prolonged Protection against Experimental Gonococcal Infection.
Parzych EM; Gulati S; Zheng B; Bah MA; Elliott STC; Chu JD; Nowak N; Reed GW; Beurskens FJ; Schuurman J; Rice PA; Weiner DB; Ram S
mBio; 2021 Mar; 12(2):. PubMed ID: 33727348
[TBL] [Abstract][Full Text] [Related]
12. Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine.
Marjuki H; Topaz N; Joseph SJ; Gernert KM; Kersh EN; ; Wang X
mBio; 2019 Sep; 10(5):. PubMed ID: 31506309
[TBL] [Abstract][Full Text] [Related]
13. Presence of antibodies to the major anaerobically induced gonococcal outer membrane protein in sera from patients with gonococcal infections.
Clark VL; Knapp JS; Thompson S; Klimpel KW
Microb Pathog; 1988 Nov; 5(5):381-90. PubMed ID: 3148817
[TBL] [Abstract][Full Text] [Related]
14. Phase and antigenic variation of pili and outer membrane protein II of Neisseria gonorrhoeae.
Sparling PF; Cannon JG; So M
J Infect Dis; 1986 Feb; 153(2):196-201. PubMed ID: 2418125
[No Abstract] [Full Text] [Related]
15. Phase variation leads to the misidentification of a Neisseria gonorrhoeae virulence gene.
Anderson MT; Seifert HS
PLoS One; 2013; 8(8):e72183. PubMed ID: 23977246
[TBL] [Abstract][Full Text] [Related]
16. Innate recognition by neutrophil granulocytes differs between Neisseria gonorrhoeae strains causing local or disseminating infections.
Roth A; Mattheis C; Muenzner P; Unemo M; Hauck CR
Infect Immun; 2013 Jul; 81(7):2358-70. PubMed ID: 23630956
[TBL] [Abstract][Full Text] [Related]
17. The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae.
Leduc I; Connolly KL; Begum A; Underwood K; Darnell S; Shafer WM; Balthazar JT; Macintyre AN; Sempowski GD; Duncan JA; Little MB; Rahman N; Garges EC; Jerse AE
PLoS Pathog; 2020 Dec; 16(12):e1008602. PubMed ID: 33290434
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of antibodies against Neisseria gonorrhoeae opacity protein loops.
Cole JG; Jerse AE
PLoS One; 2009 Dec; 4(12):e8108. PubMed ID: 19956622
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of two novel Neisseria gonorrhoeae virulent components: the macrophage infectivity potentiator and the outer membrane protein A.
Starnino S; Leuzzi R; Ghisetti V; De Francesco MA; Cusini M; Impara G; Galluppi E; Pizza M; Stefanelli P
New Microbiol; 2010 Apr; 33(2):167-70. PubMed ID: 20518279
[TBL] [Abstract][Full Text] [Related]
20. Construction and characterization of a derivative of Neisseria gonorrhoeae strain MS11 devoid of all opa genes.
LeVan A; Zimmerman LI; Mahle AC; Swanson KV; DeShong P; Park J; Edwards VL; Song W; Stein DC
J Bacteriol; 2012 Dec; 194(23):6468-78. PubMed ID: 23002223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]